We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of three late-breaking trials that are expected to have an impact on interventional science and clinical practice.
Trials covered in detail include:
EBC TWO Five-Year Follow-Up: Two-Stent Vs One for Large Bifurcation Lesions
BASILICA Vs Chimney-Stenting for TAVR-Related Coronary Obstruction
KISS: Provisional Stenting in Bifurcation Lesion: Benefit of Side Branch Intervention
Recorded on-site at EuroPCR 2023, Paris.
Visit Radcliffe Cardiology: www.radcliffecardiology.com/
Visit Radcliffe Vascular: www.radcliffevascular.com/
This content is intended for healthcare professionals only.
Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.
Like us on Facebook: RadcliffeCardiology
Follow us on X: x.com/radcliffeCARDIO